Corporate

Overview

At Michael Best, we understand the value of long-term relationships. Clients count on our Corporate group for strategic legal counsel throughout the entire business life cycle — from organization, financing, and operation through mergers, acquisitions, divestitures, and liquidation.

Our clients span many different industries and include all sizes of public and private companies, individual and institutional investors, family and wealth preservation and transfer trusts, and other business entities. We work closely with each client to develop a deep understanding of its business, objectives, communication styles, and company culture.

Our Corporate service areas are listed below and briefly outlined on the linked pages. Because each client is unique, we employ a tailored approach to deliver the right combination of legal services and guidance at every stage of business.

 

Service Areas

Securities & Capital Markets

Our Securities & Capital Markets team advises public as well as private companies in securities offerings and private placements. For publicly traded companies, we handle a full range of securities reporting and compliance matters, M&A transactions, and securities litigation. In addition, we provide counsel on broker-dealer and investment adviser regulatory issues. Specific areas of expertise include:

  • Public & Private Company Financings
  • Public Company Reporting & Compliance
  • Mergers & Acquisitions for Public Companies
  • Broker-Dealer/FINRA Matters
  • Investment Adviser
  • Securities Enforcement & Litigation
  • Derivatives

Click here to learn more.

Transactions

Michael Best represents clients in all types of transactions including mergers and acquisitions, restructurings, joint ventures, and other partnerships, as well as different types of finance and lending, and derivatives. Our Transactions team has deep experience with significant transactions, covering every angle from corporate governance and taxation to intellectual property licensing or environmental due diligence. Some of ours specific service areas include:

Click here to learn more.

General Corporate Counsel

Michael Best has served as corporate counsel to thousands of clients, assisting with commercial contracts, corporate governance issues, and other legal aspects of running a business. We provide a customized mix of services, from periodic support to acting as outside general counsel. Some select services include:

Click here to learn more.

Venture Capital & Private Equity

Our Venture Capital & Private Equity group has extensive experience in the financial industry, not only as attorneys, but also as investors and entrepreneurs. We represent clients in investment fund formation, private equity investments, venture capital and growth capital financing, and forming and growing start-ups.

Click here to learn more.

Healthcare

We serve diverse clients throughout the healthcare sector. Our Healthcare group has a deep understanding of the industry’s complex market forces and regulatory environment, combined with the capability to provide a full suite of legal services.

Click here to learn more.

Experience

  • Represented one of the world’s largest manufacturers of frozen foods in its acquisition of substantially all the assets of a frozen food manufacturer and distributor. We provided counsel in all aspects of M&A, including due diligence, document drafting, and structuring for tax purposes.
  • Represented a regenerative medicine company in its merger with a global specialty biopharmaceutical company, which involved cash consideration at closing and cash consideration tied to certain FDA regulatory approvals and revenue from product sales.
  • Represented a pharmaceutical company that develops novel compounds for the treatment of schizophrenia and other central nervous system disorders. Michael Best advised the company in negotiating the terms of a $26 million Series C financing and in corporate governance matters related to the financing.
  • Represented the lead investor in a Wisconsin-based developer of new technologies and production methodologies in nuclear medicine through its first three rounds of financing. The developer undertook a complex recapitalization to simplify its capital structure and position itself for new financing. We represented the lead investor in negotiating the terms of the recapitalization and a new $20 million convertible note financing. The developer is among those to create a domestic source of molybdenum-99 (Moly 99), the basis for the medical isotope technetium-99, which is used in medical scans to diagnose heart disease and cancer.

Primary Contact

back to top